Vladimir Katanaev


Publication list, 2014-2019. ResearcherID: F-9480-2014. ORCID ID: 0000-0002-7909-5617.

* indicates senior authorship.


  • Lian S, Xie R, Ye Y, Xie X, Li S, Lu Y, Li B, Cheng Y, Katanaev VL, Jia L. Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release. (2019) EBioMedicine, 42: 281-295. DOI: /10.1016/j.ebiom.2019.03.018.
  • Ahmed K, Koval A, Xu J, Bodmer A, Katanaev* VL. Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor. (2019) Cancer Letters, 449: 45-55. DOI: 10.1016/j.canlet.2019.02.018.
  • Righi D, Marcourt L, Koval A, Ducret V, Pellissier L, Mainetti A, Katanaev VL, Perron K, Wolfender JL, Queiroz EF. Chemo-diversification of plant extracts using a generic bromination reaction and monitoring by metabolite profiling. (2019) ACS Combinatorial Science, 21(3): 171-182. DOI: 10.1021/acscombsci.8b00132.
  • Shaw HV, Koval A, Katanaev* VL. A High-Throughput Assay Pipeline for Specific Targeting of Frizzled GPCRs in Cancer. (2019) Methods in Cell Biology, 149: 57-75. Volume: G Protein-Coupled Receptors, 2nd Edition, Part B. DOI: 10.1016/bs.mcb.2018.08.006.



  • Koval A, Pieme CA, Queiroz EF, Ragusa S, Ahmed K, Blagodatski A, Wolfender JL, Petrova TV, Vladimir L. Katanaev* VL. Tannins from Syzygium guineense suppress Wnt signaling and proliferation of Wnt-dependent tumors through a direct effect on secreted Wnts. (2018) Cancer Letters, 435: 110-120. DOI: 10.1016/j.canlet.2018.08.003.
  • Büscher TH, Kryuchkov M, Katanaev VL, Gorb SN. Versatility of Turing patterns potentiates rapid evolution in tarsaladhesive microstructures of stick and leaf insects (Phasmatodea). (2018) Journal of the Royal Society Interface, 15: 20180281. DOI: 10.1098/rsif.2018.0281.
  • Koval A, Ahmed K, Katanaev* VL. Dramatic dysbalancing of the Wnt pathway in breast cancers. (2018) Scientific Reports, 8:7329. DOI: 10.1038/s41598-018-25672-6.
  • Katanaev VL, Egger-Adam D, Tomlinson A. Antagonistic PCP Signaling Pathways in the developing Drosophila eye. (2018) Scientific Reports, 8:5741. DOI: 10.1038/s41598-018-24053-3.
  • Keshelava A, Solis GP, Hersch M, Koval A, Kryuchkov M, Bergmann S, Katanaev* VL. High capacity in G protein-coupled receptor signaling. (2018) Nature Communications, 9: 876. DOI: 10.1038/s41467-018-02868-y.
  • Zhuge W, Chen R, Katanaev V, Dong X, Zia K, Sun X, Dai X, Bao M, Shen X, Liang G. Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer. (2018) Cancer Letters, 412: 46-58. DOI: doi.org/10.1016/j.canlet.2017.10.006.
  • Blagodatski A, Yatsunskaya M, Mikhailova V, Tiasto V, Kagansky A, Katanaev* VL. Medicinal mushrooms as an attractive new source of natural compounds for future anticancer therapy. (2018) Oncotarget, 9 (49): 29259-74. DOI: 10.18632/oncotarget.25660.
  • Solis GP, Katanaev* VL. Gαo Encephalopathies: Plasma Membrane vs. Golgi functions. (2018) Oncotarget, 9 (35): 23846-7. DOI: 10.18632/oncotarget.22067.
  • Kryuchkov M, Blagodatski A, Cherepanov V, Katanaev* VL. Arthropod corneal nanocoatings: diversity, mechanisms, and functions. (2018) Invited book chapter to: Functional Surfaces in Biology III of the Springer Thematic Series Biologically Inspired Systems. Editors: Gorb E, Gorb S., ISBN 978-3-319-74144-4. DOI: 10.1007/978-3-319-74144-4_2.
  • Katanaev VL, Kryuchkov M. Insect corneal type nanocoatings. European patent application EP18175103.3, filed 30.08.2018.
  • Katanaev VL, Koval A. Novel class of inhibitors of the Wnt signaling pathway. European patent application EP18159649.5, filed 02.03.2018.



  • Olivon F, Allard PM, Koval A, Righi D, Genta-Jouve G, Neyts J, Apel C, Pannecouque C, Nothias LF, Cachet X, Marcourt L, Roussi F, Katanaev V, Touboul D, Wolfender JL, Litaudon M. Bioactive natural products prioritization using massive multiinformational molecular networks. (2017) ACS Chemical Biology, 12(10): 2644-51. DOI: 10.1021/acschembio.7b00413.
  • Blagodatski A, Cherepanov V, Koval A, Kharlamenko VI, Khotimchenko YS, Katanaev* VL. High-throughput targeted screening in triple-negative breast cancer cells identifies Wnt-inhibiting activities in Pacific brittle stars. (2017) Scientific Reports, 7:11964. DOI: 10.1038/s41598-017-12232-7.
  • Kryuchkov M, Lehmann J, Schaab J, Cherepanov V, Blagodatski A, Fiebig M, Katanaev* VL. Alternative moth-eye nanostructures: antireflective properties and composition of dimpled corneal nanocoatings in silk-moth ancestors. (2017) Journal of Nanobiotechnology, 15:61. DOI: 10.1186/s12951-017-0297-y.
  • Solis GP, Bilousov O, Lüchtenborg AM, Koval A, Lin C, Katanaev* VL. Golgi-resident Gαo promotes protrusive membrane dynamics. (2017) Cell, 170 (5): 939-55. DOI: 10.1016/j.cell.2017.07.015.
  • Kryuchkov M, Lehmann J, Schaab J, Fiebig M, Katanaev* VL. Antireflective nanocoatings for UV-sensation: the case of predatory owlfly insects. (2017) Journal of Nanobiotechnology, 15:52. DOI: 10.1186/s12951-017-0287-0.
  • Ansermet C, Moor MB, Centeno G, Auberson M, Hu DZ, Baron R, Nikolaeva S, Haenzi B, Katanaeva N, Gautschi I, Katanaev VL, Rotman S, Koesters R, Schild L, Pradervand S, Bonny O, Firsov D. Renal Fanconi syndrome and hypophosphatemic rickets in mice deficient for retroviral receptor XPR1 in the nephron. (2017) Journal of the American Society of Nephrology, 28(4): 1073-8. DOI: 10.1681/ASN.2016070726. Best paper of the year by the Swiss Society of Nephrology.
  • Moon S, Kim W, Kim S, Kim Y, Song Y, Bilousov O, Kim J, Lee T, Cha B, Kim M, Kim H, Katanaev* VL, Jho EH. NLK phosphorylates and potentiates YAP activity by regulating interaction with 14-3-3 and nuclear localization. (2017) EMBO Reports, 18(1): 61-71. DOI: 10.15252/embr.201642683. News & Views in EMBO Reports: 18(1): 3-4. Covered by EMBO Encounters, 35:19. Graded as “Recommended” by the Faculty of 1000 Biology, with the F1000 Article Factor 2.0.
  • Shrivastava S, Jeengar MK, Thummuri D, Koval A, Katanaev VL, Marepally S, Naidu VGM. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial– mesenchymal transition. (2017) BioFactors, 43(2): 152-69. DOI: 10.1002/biof.1315.



  • Koval A, Ahmed K, Katanaev* VL. Inhibition of Wnt Signaling and Breast Tumor Growth by the Multi-purpose Drug Suramin through Suppression of Heterotrimeric G Proteins and Wnt Endocytosis. (2016) Biochemical Journal, 473: 371-81.
  • Pouly D, Chenaux S, Martin V, Babis M, Koch E, Katanaev VL, Gachon F, Staub O. USP2-45 is a circadian clock output effector regulating calcium absorption at the post-translational level. (2016) PLoS ONE, 11: e0145155.
  • Ahmed K, Shaw HV, Koval A, Katanaev* VL. A second Wnt for old drugs: drug repositioning against Wnt-dependent cancers. (2016) Cancers, 8 (7), 66; DOI: 10.3390/cancers8070066.



  • Lüchtenborg AM, Purvanov V, Melnik BS, Becker S, Katanaev* VL. Mode of interaction of the Gαo subunit of heterotrimeric G proteins with the GoLoco1 motif of Drosophila Pins is determined by guanine nucleotides. (2015) Bioscience Reports 35: e00271.
  • Hülsbusch N, Solis GP, Katanaev VL, Stuermer C. Reggie-1/Flotillin-2 regulates integrin trafficking and focal adhesion turnover via Rab11a. (2015) European Journal of Cell Biology, 94(11): 531-45.
  • Blagodatski A, Sergeev A, Kryuchkov M, Lopatina Y, Katanaev* VL. A diverse set of Turing nanopatterns coat corneae across insect lineages. (2015) Proc. Natl. Acad. Sci. U.S.A., 112(34): 10750-5.
  • Sergeev A, Timchenko AA, Kryuchkov M, Blagodatski A, Enin GA, Katanaev* VL. Origin of order in bionanostructures. (2015) RSC Advances, 5: 63521-7.



  • Lüchtenborg AM, Katanaev* VL. Lack of evidence of the interaction of the Abeta peptide with the Wnt signaling cascade in Drosophila models of Alzheimer's disease. (2014) Molecular Brain, 7:81.
  • Lüchtenborg AM, Solis GP, Egger-Adam D, Lin C, Koval A, Blanchard MG, Kellenberger S, Katanaev* VL. Heterotrimeric Go protein links Wnt-Frizzled signaling with Ankyrins to regulate the neuronal microtubule cytoskeleton. (2014) Development, 141(17): 3399-409.
  • Blagodatski A, Kryuchkov M, Sergeev A, Enin GA, Katanaev* VL. Under- and over-water halves of Gyrinidae beetle eyes harbor different corneal nanocoatings providing adaptation the water and air environments. (2014) Scientific Reports 4:6004.
  • Bilousov O, Koval A, Keshelava A, Katanaev* VL. Identification of novel elements of the Drosophila blisterome sheds light on potential pathological mechanisms of several human diseases. (2014) PLoS ONE 9: e101133.
  • Galkina OL, Sycheva A, Blagodatskiy A, Kaptay G, Katanaev VL, Seisenbaeva GA, Kessler VG, Agafonov AV. The Sol-Gel Synthesis of Cotton/TiO2 Composites and their Antibacterial Properties. (2014) Surface and Coatings Technology, 253: 171-9.
  • Lin C, Koval A, Tishchenko S, Gabdulkhakov A, Tin U, Solis G, Katanaev* VL. Double suppression of the Galpha protein activity by RGS proteins. (2014) Molecular Cell, 53(4): 663-71.
  • Ignatious Raja JS, Katanayeva N, Katanaev* VL, Galizia CG. Go/i beta-gamma subunits contribute to Drosophila melanogaster olfactory receptor signaling. (2014) European Journal of Neuroscience 39: 1245-55.
  • Koval AV, Vlasov P, Shichkova P, Khunderyakova S, Markov Y, Panchenko J, Volodina A, Kondrashov FA, Katanaev* VL. Anti-Leprosy Drug Clofazimine Inhibits Growth of Triple-Negative Breast Cancer Cells via Inhibition of Canonical Wnt Signaling. (2014)  Biochemical Pharmacology 87(4): 571-8.
  • Blagodatski A, Poteryaev D, Katanaev* VL. Targeting the Wnt Pathway for Therapies. (2014) Molecular and Cellular Therapies, 2:28.
  • Katanaev VL. Prospects of targeting Wnt signaling in cancer. (2014) Journal of Pharmacology and Toxicology Research, 1: 1-3.
  • Katanaev VL, Koval A, Blagodatski A. Wnt7a polypeptides and their use. European patent application 20140718, filed 18.07.2014.